ClinicalTrials.govpublic full text
Avelumab in Refractory Testicular Germ Cell Cancer.
testicular neoplasms, neoplasms, germ cell and embryonal, neoplasms, testicular diseases, gonadal disorders, antineoplastic agents, molecular mechanisms of pharmacological action, multiple relapsed/refractory testicular germ cell tumors, avelumab, anti pd-l1, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979830
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.